JPH07196478A - Soft capsule for highly safe food and medicine - Google Patents
Soft capsule for highly safe food and medicineInfo
- Publication number
- JPH07196478A JPH07196478A JP5351267A JP35126793A JPH07196478A JP H07196478 A JPH07196478 A JP H07196478A JP 5351267 A JP5351267 A JP 5351267A JP 35126793 A JP35126793 A JP 35126793A JP H07196478 A JPH07196478 A JP H07196478A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- soft
- soft capsule
- liquid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 74
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 235000013305 food Nutrition 0.000 title claims abstract description 12
- 239000002775 capsule Substances 0.000 claims abstract description 97
- 239000007788 liquid Substances 0.000 claims abstract description 48
- 229920001817 Agar Polymers 0.000 claims abstract description 28
- 239000008272 agar Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000011248 coating agent Substances 0.000 claims abstract description 17
- 238000000576 coating method Methods 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000021120 animal protein Nutrition 0.000 claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004014 plasticizer Substances 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- 235000015110 jellies Nutrition 0.000 claims abstract description 4
- 239000008274 jelly Substances 0.000 claims abstract description 4
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 3
- 239000000783 alginic acid Substances 0.000 claims abstract description 3
- 229920000615 alginic acid Polymers 0.000 claims abstract description 3
- 229960001126 alginic acid Drugs 0.000 claims abstract description 3
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 3
- 230000005484 gravity Effects 0.000 claims abstract description 3
- 235000005473 carotenes Nutrition 0.000 claims description 48
- 150000001746 carotenes Chemical class 0.000 claims description 48
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 45
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 45
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 39
- 229930003427 Vitamin E Natural products 0.000 claims description 19
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 19
- 235000019165 vitamin E Nutrition 0.000 claims description 19
- 229940046009 vitamin E Drugs 0.000 claims description 19
- 239000011709 vitamin E Substances 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 18
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000008157 edible vegetable oil Substances 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000035939 shock Effects 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 25
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000001125 extrusion Methods 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 description 17
- 239000000654 additive Substances 0.000 description 17
- 239000008273 gelatin Substances 0.000 description 17
- 229920000159 gelatin Polymers 0.000 description 17
- 235000019322 gelatine Nutrition 0.000 description 17
- 235000011852 gelatine desserts Nutrition 0.000 description 17
- 239000010408 film Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 241000282887 Suidae Species 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 235000020774 essential nutrients Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000007902 hard capsule Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、食品及び医薬品用のソ
フトカプセルに関する。FIELD OF THE INVENTION The present invention relates to soft capsules for food and medicine.
1.動物性タンパク質を含まない易溶解性のソフトカプ
セルについて ソフトカプセルは一般にゼラチンをゲル化及び造膜性基
剤とする皮膜により非水性液を封入した固形物であり、
用途としては医薬品が多いが、最近では肝油、EPA、
ニンニク油、月見草油等の健康食品、調味油等の一般加
工食品、バスオイルカプセル、化粧品などの分野で使わ
れている。製法としては、打ち抜き法(スタンピング
法)と滴下法(ドリッピング法)の2種類が知られてい
るが、一般には、スタンピング法の1種であるライナー
式又はシェーラー式ロータリーダイ法及び滴下法の1種
である液中硬化法が使われている。1. About easy-to-dissolve soft capsules that do not contain animal protein Soft capsules are solids that generally enclose non-aqueous liquid with a film that uses gelatin as a gelling and film-forming base.
Mostly used as pharmaceuticals, but recently liver oil, EPA,
It is used in the fields of health foods such as garlic oil and evening primrose oil, general processed foods such as seasoning oils, bath oil capsules, and cosmetics. There are two known manufacturing methods, a punching method (stamping method) and a dropping method (dripping method). Generally, one of the stamping methods is a liner type or Scheller type rotary die method and a dropping method. One type of liquid curing method is used.
【0002】従来のソフトカプセルは、その皮膜基剤と
して牛、豚などの恒温動物由来のゼラチンが用いられて
きたが、ソフトカプセルの普及にともない、ゼラチンの
問題点として、次の様な点が指摘されている。 1)ゼラチンは、牛、豚等の恒温動物由来のタンパク質
であるため、菜食主義者や宗教上の理由等で摂取できな
い人がいる。 2)ゼラチンは、牛、豚等の恒温動物由来のタンパク質
であるが、人間も同じ恒温動物であるため、英国の牛の
狂脳病など、牛、豚の病気あるいはゼラチンの製造工程
における汚染菌、汚染物質は、植物由来原料に比し、人
間に対する感染・汚染の危険度が高い。In conventional soft capsules, gelatin derived from homeothermic animals such as cows and pigs has been used as a film base, but with the widespread use of soft capsules, the following problems have been pointed out as problems with gelatin. ing. 1) Gelatin is a protein derived from constant temperature animals such as cows and pigs, so some people cannot eat it due to vegetarianism or religious reasons. 2) Gelatin is a protein derived from homeothermic animals such as cows and pigs, but humans are the same homeothermic animals. Therefore, the disease of cows and pigs such as mad encephalopathy of cattle in the UK, or contaminating bacteria in the gelatin manufacturing process. However, pollutants have a higher risk of infection / contamination to humans than plant-derived materials.
【0003】3)ゼラチンは動物性タンパク質であるた
め、摂取後副作用としてアレルギーを示す人がいる。 4)錠剤やハードカプセル等の他の固形剤に比し、ゼラ
チン製ソフトカプセルは耐熱性、耐湿性に劣り、保管上
の問題点がある。一方、最近になりカプセル皮膜が寒天
性のソフトカプセルも報告されているが、寒天は低温
(体温以下)の水に不溶性である。このため、この従来
の寒天カプセルは服用後カプセル内容液を体内で放出す
るか否かを確認するための崩壊試験を行っても、体温
(37°C)の人工胃液、水、人工腸液中では数時間以
上たってもカプセル皮膜が溶解せず、有効成分であるカ
プセル内容液の放出が見られない。3) Since gelatin is an animal protein, some people have allergies as a side effect after ingestion. 4) Compared with other solid agents such as tablets and hard capsules, gelatin soft capsules are inferior in heat resistance and moisture resistance and have problems in storage. On the other hand, recently, soft capsules having an agar capsule film have been reported, but agar is insoluble in water at low temperatures (below body temperature). Therefore, even if this conventional agar capsule is subjected to a disintegration test for confirming whether or not the capsule content liquid is released in the body after taking, in the artificial gastric fluid, water, and artificial intestinal fluid at body temperature (37 ° C), Even after several hours or more, the capsule film does not dissolve, and no release of the capsule content liquid as the active ingredient is observed.
【0004】カプセル内容液中の有効成分が体内で放出
されなければ、これはソフトカプセルとしては致命的欠
点である。又、従来の寒天カプセルは強度が低く、流通
あるいは保管期間中のカプセルの割れ等の問題がある。
このため現在市販のソフトカプセルは依然としてほとん
どすべてがゼラチン製であり、前記の問題点は解決され
ていない。If the active ingredient in the capsule content liquid is not released in the body, this is a fatal defect as a soft capsule. In addition, the conventional agar capsules have low strength, and there are problems such as capsule cracking during distribution or storage.
Therefore, almost all of the currently available soft capsules are made of gelatin, and the above problems have not been solved.
【0005】2.カプセル内容液中に添加物を含まない
カロチンソフトカプセルについて近年、健康食品あるい
は医薬品等の有効成分としてカロチン類が注目されてい
る。カロチンはビタミンAと同様、生体の健康維持に必
要な栄養素の一つであるが、最近では単なる栄養素とし
ての効果以上に、循環器疾患や癌に対して予防効果を持
つことが医学界で相次いで報告され、注目されている。2. About carotene soft capsule containing no additive in the capsule content liquid In recent years, carotene has attracted attention as an active ingredient of health foods, pharmaceuticals and the like. Like vitamin A, carotene is one of the nutrients necessary for maintaining the health of the body, but recently it has been shown in the medical community that it has a preventive effect on cardiovascular disease and cancer, in addition to its effect as a simple nutrient. It has been reported and is attracting attention.
【0006】このカロチンはやはり、通常の食事を通し
て摂取するのが最も好ましいが、食事のみで充分量を効
率よく摂取するのは難しい為、栄養補助食品としてカロ
チンを高含有量で含む錠剤、ハードカプセル、ソフトカ
プセル等が市販されている。カロチン類はビタミンAと
同様、空気酸化されやすい事から、カロチンの結晶(純
品)は窒素置換した密封容器で冷所保存する必要があ
る。又、錠剤、ハードカプセル等の剤型では空気による
酸化に対してはやはり不安定であるため、カロチンを食
用油に溶解又は分散させ、ゼラチン製皮膜内に封入した
カロチン高含有のソフトカプセルが一般に市販されてい
る。[0006] This carotene is also most preferably taken through a normal diet, but it is difficult to efficiently ingest a sufficient amount with food alone. Therefore, tablets, hard capsules containing a high content of carotene as a dietary supplement, Soft capsules are commercially available. Since carotene is likely to be air-oxidized like vitamin A, carotene crystals (pure products) must be stored in a cold place in a sealed container in which nitrogen is replaced. In addition, since tablets, hard capsules and other dosage forms are still unstable against oxidation by air, carotene-rich soft capsules that are dissolved or dispersed in edible oil and enclosed in a gelatin film are generally commercially available. ing.
【0007】このカロチンは一般に室温では固体(粉
末)であるが、ソフトカプセルは油性の液状物しかカプ
セル化できない為、市販のカロチン含有健康食品はカロ
チン又は、カロチン含有油液を原料としてこの所定量に
対して、食用油、抗酸化剤などを加え、カプセル化可能
な粘度の液状油としたのち、カプセル化している。しか
し、カロチン又は、カロチン含有油液に単に食用油を加
えただけでは、カロチンが重力により沈降し、経時的に
油層とカロチンの沈降層とにソフトカプセル内で分離す
る。このため、市販品のほとんどは食品添加物の脂肪酸
モノグリセライド(モノグリ)あるいはミツロウ等の増
粘剤、分散剤を加えてカロチンの沈降を防ぎ、経時的な
外観の変化のない商品としている。[0007] This carotene is generally a solid (powder) at room temperature, but since soft capsules can only encapsulate oily liquids, commercially available carotene-containing health foods are made from carotene or a carotene-containing oil liquid at a predetermined amount. On the other hand, edible oil, antioxidant and the like are added to make a liquid oil having a viscosity capable of being encapsulated and then encapsulated. However, simply adding edible oil to carotene or a carotene-containing oil solution causes carotene to settle due to gravity, and to separate with time into an oil layer and a carotene settling layer in the soft capsule. For this reason, most of the commercially available products are added with a thickener such as fatty acid monoglyceride (monoglyceride) or beeswax as a food additive or a dispersant to prevent carotene from settling, so that the appearance does not change with time.
【0008】しかし、健康食品は、加工食品や食品添加
物の乱用による健康への悪影響を防ぐ目的で使われてい
る面もあり、このような添加物の使用は、本来は好まし
いことではない。このため、添加物を用いず、カプセル
内容液が沈降・分離した商品も市販されている。しか
し、カプセル内容液が経時的に2層に分離すると外観上
やはり商品価値が落ち、添加物を使用しなくとも経時的
に安定なカロチン製剤の開発が要望されている。However, health foods are also used for the purpose of preventing adverse effects on health due to abuse of processed foods and food additives, and the use of such additives is not originally preferable. Therefore, a product in which the capsule content liquid is precipitated and separated without using any additive is also commercially available. However, when the capsule content liquid separates into two layers over time, the commercial value also deteriorates in appearance, and there is a demand for the development of a carotene formulation that is stable over time without the use of additives.
【0009】[0009]
1.動物性タンパク質を含まない易溶解性のソフトカプ
セルについて ソフトカプセルの場合その製法上、膜基剤として用いる
素材が具備しなければならない物理的、化学的性質はい
ろいろあるが、絶対的に必要な物性は熱によるゾルゲル
性である。このため、天然の可食性のゲル化素材につい
て調査、研究したところ、水に易溶解性の可食性高分子
物質を造膜性基剤とし、これにゲル化造膜性基剤とし
て、寒天又は低分子寒天及び可塑剤を加えた三種の成分
を組み合わせることにより、ソフトカプセル皮膜として
前記の問題点を解決できることを見出した。1. Easy-to-dissolve soft capsules containing no animal protein In the case of soft capsules, there are various physical and chemical properties that the material used as the membrane base must have in the manufacturing process, but the absolutely necessary physical properties are heat. It is a sol-gel type. Therefore, as a result of investigating and researching a natural edible gelling material, an edible polymer substance that is easily soluble in water was used as a film-forming base, and as a gelling film-forming base, agar or It has been found that the above-mentioned problems can be solved as a soft capsule film by combining three kinds of components including low molecular weight agar and a plasticizer.
【0010】なお、寒天及びその関連物質についてもさ
らに検討した結果、ゼリー強度300g/cm2以下の
寒天(以下低分子寒天と称す)がカプセル成形に必要な
適度のゲル化能、造膜性を示し、良好なソフトカプセル
を製することを見出した。しかし寒天は日本薬局方、米
国薬局方では次の様に定義している。「寒天1gに水6
5mlを加え、10分間絶えずかき混ぜながら煮沸して
溶かし、蒸発した水分を熱湯で補う。この液は澄明であ
り、30〜39°Cに冷却するとき弾力性のゲルとな
り、これを加熱するとき、85°C以下で溶けない。」As a result of further examination of agar and its related substances, agar having a jelly strength of 300 g / cm 2 or less (hereinafter referred to as low molecular agar) has an appropriate gelling ability and film forming property required for capsule molding. And found to make good soft capsules. However, agar is defined by the Japanese Pharmacopoeia and the US Pharmacopoeia as follows. "1g of agar and 6 parts of water
Add 5 ml and boil for 10 minutes with constant stirring to dissolve it, and replace the evaporated water with boiling water. This liquid is clear and becomes an elastic gel when cooled to 30 to 39 ° C, and does not melt at 85 ° C or lower when heated. "
【0011】これに対し、前記低分子寒天は30〜39
°Cで弾力性のあるゲルとはならず、85°C以下でも
溶解するため、通常の意味では寒天とは言えないが、原
料、製法的には分子量の低い寒天であるので、低分子寒
天として、本発明に加えた。本ソフトカプセルにおい
て、皮膜のゲル化剤及び造膜成分として用いられる寒天
は、紅藻類の細胞壁成分で、主成分はアガロースであ
り、水に不溶性の食物繊維の多い食品として知られてい
る。低濃度で強力なゲル化能を示し、ゼリー強度は一般
的には400〜500g/cm2以上である。On the other hand, the low molecular weight agar is 30 to 39.
Since it does not become an elastic gel at ° C and dissolves even at 85 ° C or less, it cannot be called agar in the ordinary sense, but it is agar with a low molecular weight according to the raw material and the manufacturing method. The present invention is added to the present invention. In this soft capsule, agar used as a gelling agent for the film and a film-forming component is a cell wall component of red algae, the main component of which is agarose, and it is known as a food containing a large amount of dietary fiber that is insoluble in water. It exhibits a strong gelling ability at a low concentration, and the jelly strength is generally 400 to 500 g / cm 2 or more.
【0012】しかし、前述のとおり寒天は85°C以下
の水には不溶性であるため、寒天のみを皮膜の造膜成分
とするカプセルは、可塑剤を加えても日本薬局方のソフ
トカプセルの崩壊試験においても溶解せず、カプセル内
容物を放出しない。医薬品、食品用ソフトカプセルは服
用後体内(消化器)で崩壊し、有効成分であるカプセル
内容液を体内に放出し、腸から吸収されることを前提と
しており、崩壊試験において内容液を放出しないという
のは、医薬品、食品用ソフトカプセルとしては致命的な
欠点である。However, as mentioned above, since agar is insoluble in water at 85 ° C. or lower, capsules containing only agar as the film-forming component of the film are disintegrated in the soft capsule of the Japanese Pharmacopoeia even if a plasticizer is added. It does not dissolve and does not release the capsule contents. Soft capsules for medicines and foods are supposed to be disintegrated in the body (digestive organ) after taking, to release the capsule content liquid which is the active ingredient into the body, and to be absorbed from the intestine, and not to release the content liquid in the disintegration test. Is a fatal drawback for soft capsules for medicines and foods.
【0013】又、寒天はその粘度が高い関係で配合率を
増やすことが困難であるため、カプセルの皮膜厚が薄
く、カプセル強度も低い。このため、流通・保管時にカ
プセルが割れやすく商品価値を著しく損なう。従ってこ
の寒天カプセルのこれらの欠点を補う可食性高分子物質
について調査した結果、体温以下の水に溶解しやすい低
粘度の可食性の高分子物質(アルギン酸及びその塩類、
カラギーナン、キサンタンガム、ジェランガム、ローカ
ストビーンガム、デキストリン、プルランなど)及びグ
リセリン、ソルビトールなどの可塑剤を寒天とともに皮
膜中に配合すると、日本薬局方の崩壊試験にも適合し、
カプセル強度も高めることができた。ここでいう水に溶
解しやすい高分子物質とは、前記の物質に限定されるも
のでなく、次の条件を有する食用高分子物質でも代替可
能である。Further, since agar has a high viscosity and it is difficult to increase the compounding ratio, the capsule has a thin film thickness and a low capsule strength. For this reason, the capsule is easily broken during distribution and storage, and the commercial value is significantly impaired. Therefore, as a result of investigating an edible polymer substance that compensates for these drawbacks of this agar capsule, a low-viscosity edible polymer substance (alginic acid and its salts, which is easily dissolved in water at body temperature or lower,
Carrageenan, xanthan gum, gellan gum, locust bean gum, dextrin, pullulan, etc.) and glycerin, and plasticizers such as sorbitol are added to the agar together with the agar, it is also compatible with the Japanese Pharmacopoeia disintegration test,
The capsule strength could also be increased. The polymer substance which is easily dissolved in water as used herein is not limited to the above substances, and an edible polymer substance having the following conditions can be substituted.
【0014】1)動物性タンパク質を含まない物質であ
ること。 2)37°C以下の水に溶解し、その1%水溶液の粘度
が70°C1000cps以下と低粘度であり、この水
溶液を油中に滴下すると、界面張力により球状となるこ
と。 3)可食性であること。又、ここでいう可塑剤とは、前
記物質に限定されるものではなく、一般のゼラチン製ソ
フトカプセルの可塑剤として使用可能な物質(可塑剤、
保水性のある物質)で非動物性タンパク質であれば、代
替することも可能である。1) A substance containing no animal protein. 2) It is dissolved in water at 37 ° C. or lower, and the viscosity of its 1% aqueous solution is as low as 70 ° C. and 1000 cps, and when this aqueous solution is dropped into oil, it becomes spherical due to interfacial tension. 3) Must be edible. Further, the plasticizer referred to here is not limited to the above-mentioned substances, but a substance that can be used as a plasticizer for general gelatin soft capsules (plasticizer,
A non-animal protein can be substituted as long as it is a water-retaining substance).
【0015】又、前記以外の成分として、通常のソフト
カプセルの皮膜に配合できる成分、例えば防腐剤、着色
剤、不透明化剤、着香剤、矯味剤等も必要により適宜用
いることができる。又、本ソフトカプセルの製法は、各
皮膜成分の接着性(ヒートシール性)が少ないため、ス
タンピング法では製造することはできず、ドリッピング
法によるものである。ドリッピング法の基本原理及び装
置は次のとおりである。In addition to the above components, components that can be added to the film of a normal soft capsule, such as preservatives, coloring agents, opacifying agents, flavoring agents, and corrigents, can be appropriately used if necessary. In addition, since the soft capsules cannot be manufactured by the stamping method, the soft capsules cannot be manufactured by the stamping method because the adhesiveness (heat sealing property) of each film component is small. The basic principle and equipment of the dripping method are as follows.
【0016】二重又は三重の同心円状の吐出口(ノズ
ル)の内側の吐出口からカプセル内容液を、又外側の吐
出口からカプセル皮膜液を定量ポンプにより、一定速度
で油液中に吐出し、振動、衝撃、カプセル液と油液との
流速差等何らかの物理的力により、この吐出液を一定間
隔で切断し、油液とカプセル皮膜液(水溶液)との界面
張力で直径0.3〜20mmの球形のソフトカプセルに
する方法である。The capsule content liquid is discharged from the inner discharge ports of the double or triple concentric discharge ports (nozzles) and the capsule coating liquid is discharged from the outer discharge ports into the oil liquid at a constant speed. The discharge liquid is cut at regular intervals by some physical force such as vibration, shock, and a difference in flow velocity between the capsule liquid and the oil liquid, and the diameter of 0.3 ~ is obtained by the interfacial tension between the oil liquid and the capsule coating liquid (aqueous solution). This is a method of forming a 20 mm spherical soft capsule.
【0017】2.カプセル内容液中に添加物を含まない
カロチンソフトカプセルについて カロチンのソフトカプセル製剤においてカロチンの空気
酸化、沈降・分離に安定な油性の基剤について各種物質
を調査・研究したところ、驚くべきことに、医薬品及び
健康食品等において生体の必須栄養素として用いられる
トコフェロール類(ビタミンE)を基剤としてカロチン
を溶解又は分散させると、ソフトカプセル内で分離せ
ず、空気酸化に対して安定であることを見出した。2. About carotene soft capsules containing no additives in the capsule content liquid We investigated and studied various substances for an oily base that is stable to carotene's air oxidation, precipitation and separation in carotene soft capsule formulations. It has been found that when carotene is dissolved or dispersed based on tocopherols (vitamin E) used as essential nutrients of the living body in health foods and the like, it is not separated in soft capsules and is stable against air oxidation.
【0018】[0018]
1.動物性タンパク質を含まない易溶解性のソフトカプ
セルについて 本発明請求項1のソフトカプセルは下記の作用、効果を
有する。 1.ゲル化剤及び皮膜基剤が水には不溶性の寒天であり
ながら、日本薬局方の崩壊試験に適合し、有効成分を含
むカプセル内容液を体内で確実に放出する。 2.動物性タンパク質を含まないため、アレルギーが少
ない。 3.植物性であるため、菜食主義者や宗教上の理由で動
物由来の食品を摂取できない人、ゼラチンアレルギーの
人でも食することができる。又、恒温動物由来の病気や
汚染物質の危険性がない。1. About easily soluble soft capsule containing no animal protein The soft capsule of claim 1 of the present invention has the following actions and effects. 1. Although the gelling agent and the film base are water-insoluble agar, they comply with the Japanese Pharmacopoeia disintegration test and reliably release the capsule content liquid containing the active ingredient in the body. 2. Less allergic because it does not contain animal protein. 3. Since it is vegetable, it can be eaten by vegetarians, people who cannot eat animal-derived foods for religious reasons, and people who are allergic to gelatin. Moreover, there is no risk of diseases and pollutants derived from homeotherms.
【0019】4.ゼラチンはその分子中にアミノ基、カ
ルボン酸基を含む為、経時的に架橋反応をおこし、水に
不溶化する。特に、カプセル内容液がアルデヒド類、還
元性物質を含む場合は不溶化が起こりやすい。これに対
し、本発明による皮膜成分はいずれも安定であり、耐熱
性、耐酸性、対アルカリ性なども高く、経時的な崩壊時
間の延長がない。 5.本発明による皮膜成分はゼラチン製ソフトカプセル
に比し、高温(40°C以上)、多湿でも軟化・変形・
付着することがなく、保管・取扱いが容易である。4. Since gelatin contains an amino group and a carboxylic acid group in its molecule, it undergoes a crosslinking reaction over time and becomes insoluble in water. In particular, insolubilization tends to occur when the capsule content liquid contains aldehydes and reducing substances. On the other hand, all the coating components according to the present invention are stable, have high heat resistance, acid resistance, alkali resistance, etc., and do not extend the disintegration time with time. 5. Compared to gelatin soft capsules, the film component of the present invention softens / deforms even at high temperatures (40 ° C or higher) and high humidity
It does not adhere and is easy to store and handle.
【0020】6.カプセル強度が高いため、流通時ある
いは保管時の取り扱いが容易であり、カプセル破裂によ
る商品価値の低下がない。 7.本発明によるソフトカプセルはゼラチン製ソフトカ
プセルに比し、やわらかく、口中においてかみくだいて
食することが容易である。 8.本発明によるソフトカプセルはゼラチン製ソフトカ
プセルとは異なり、寒天による食物繊維補給効果も有す
る。6. Since the capsule strength is high, it is easy to handle during distribution or storage, and there is no reduction in commercial value due to capsule rupture. 7. The soft capsule according to the present invention is softer than a soft capsule made of gelatin, and is easier to chew and eat in the mouth. 8. Unlike the gelatin soft capsule, the soft capsule according to the present invention also has an effect of supplementing dietary fiber with agar.
【0021】2.カプセル内容液中に添加物を含まない
カロチンソフトカプセルについて 本発明の請求項2におけるカロチン含有ソフトカプセル
の基剤として用いるビタミンE(トコフェロール)は室
温では非常に粘調な油液性で、それ自体生体の必須栄養
素として知られており、生体の老化や成人病の原因の1
つである体内のフリーラジカルの発生を防ぎ、癌、動脈
硬化、痴呆症などに対する効果が近年注目されている。2. About carotene soft capsule containing no additive in the capsule content liquid Vitamin E (tocopherol) used as a base of the carotene-containing soft capsule in claim 2 of the present invention is a very viscous oil liquid at room temperature and is It is known as an essential nutrient and is one of the causes of aging of the body and adult diseases.
In recent years, attention has been paid to its effects on cancer, arteriosclerosis, dementia, etc., which prevent the generation of free radicals in the body.
【0022】健康食品の領域でもカロチン、ビタミン
E、ビタミンCの3つのビタミンは互いに協力して、生
体のすべての代謝系において、過酸化物質の発生を防ぐ
効果が認められ、酸化防止療法ビタミン剤としてここ数
年、欧米では急速に売り上げが伸びている。これらの商
品の製品形態はカロチン、ビタミンE、ビタミンCの3
成分を一剤中に配合したものか、又はそれぞれ単一成分
の製品などが市販されている。3成分を一剤に配合した
場合、服用するには便利である。しかし、ビタミンCは
水溶性のビタミンで服用後数時間で血中から消失するの
に対し、カロチンとビタミンEは油溶性ビタミンで服用
後十数時間で血中から消失する。このように服用後の体
内動態、血中濃度が異なるものを一つの製品中に配合
し、同一の用法・用量で服用する事は医学的には好まし
くない。医学的にはカロチンとビタミンEは一日1〜2
回、ビタミンCは1日数回に分けて服用するのが好まし
いが、3成分の単一製剤でこのように服用するのは、煩
雑となる。In the area of health foods, three vitamins, carotene, vitamin E, and vitamin C, cooperate with each other, and the effect of preventing the generation of peroxides is recognized in all metabolic systems of the living body. As a result, in the last few years, sales have been growing rapidly in Europe and America. The product forms of these products are carotene, vitamin E, and vitamin C.
Commercially available products are prepared by combining the ingredients in a single preparation, or products each containing a single ingredient. It is convenient to take when three components are combined in one drug. However, vitamin C is a water-soluble vitamin that disappears from the blood within a few hours after administration, whereas carotene and vitamin E are oil-soluble vitamins that disappear from the blood within a dozen hours after administration. In this way, it is medically unfavorable to mix the products having different pharmacokinetics and blood concentration after administration into one product and to administer them with the same usage and dose. Medically, carotene and vitamin E 1-2 times a day
It is preferable to take Vitamin C in divided doses several times a day, but it is cumbersome to take such a single preparation of three components.
【0023】従って、服用方法が同じ油溶性ビタミンの
カロチンとビタミンEを一剤(ソフトカプセル)とし、
服用方法が異なるビタミンC(一般には錠剤)との2剤
で酸化防止療法を実施するのが好ましい。本発明による
ビタミンEを基剤としたカロチンのソフトカプセルは次
の効果を有する。Therefore, the oil-soluble vitamins carotene and vitamin E, which are taken in the same manner, are treated as one agent (soft capsule),
It is preferable to carry out the antioxidant therapy with two agents of vitamin C (generally tablets) which are taken differently. The soft capsule of carotene based on vitamin E according to the present invention has the following effects.
【0024】1.市販のカロチン含有ソフトカプセル
は、増粘剤・界面活性剤などの添加物を用いてカロチン
がカプセル内で沈降・分離するのを防いでいる商品かあ
るいは添加物を使わずにカプセル内でカロチンが沈降・
分離した商品しかなかったが、本発明によるカロチン含
有ソフトカプセルは、生体の必須栄養素であるビタミン
Eを基剤として溶解・分散させることにより、カロチン
・ビタミンE・食用油以外の成分を含まない、すなわ
ち、添加物を含まない安全性及び安定性の高いソフトカ
プセルを製することができる。ここでいう添加物とは、
本発明によるソフトカプセルの内容液調合時に有効成分
以外の食品添加物等を用いないの意味であり、原料とし
て市販されているカロチン、カロチン油、ビタミンE、
ビタミンE油等に既に含まれている添加物、すなわちキ
ャリーオーバーの添加物は含まれていない。又、カロチ
ン、ビタミンE以外の有効成分、例えばビタミンD、D
HA、EPAなどは添加物ではないので、配合できる。1. Commercially available carotene-containing soft capsules are products that use additives such as thickeners and surfactants to prevent carotene from settling / separating in the capsules, or carotene settling in the capsules without using additives.・
Although there were only separated products, the carotene-containing soft capsule according to the present invention does not contain components other than carotene, vitamin E and edible oil by dissolving and dispersing vitamin E, which is an essential nutrient of the living body, as a base, that is, In addition, it is possible to manufacture soft capsules containing no additives and having high safety and stability. The additive here means
It means that no food additives other than the active ingredient are used when formulating the content liquid of the soft capsule according to the present invention, and carotenes, carotene oil, vitamin E, which are commercially available as raw materials,
Additives already contained in Vitamin E oil and the like, that is, carryover additives are not included. Also, active ingredients other than carotene and vitamin E, such as vitamins D and D
HA, EPA, etc. are not additives and can be added.
【0025】2.本発明によるソフトカプセルは体内の
吸収動態が類似しているカロチンとビタミンEを同一製
剤に配合したものであり、市販のビタミンCの単一製剤
と本剤とを併用することにより、より簡単に、しかも安
全に酸化予防療法用ビタミンを摂取できる。 3.ビタミンEはカロチンの抗酸化作用をも有してお
り、この点でも本発明によるソフトカプセルは安全性・
安定性が高い。2. The soft capsule according to the present invention is a mixture of carotene and vitamin E, which have similar absorption kinetics in the body, in the same preparation. By using a single preparation of commercially available vitamin C in combination with this preparation, it becomes easier to Moreover, you can safely take vitamins for oxidative prophylaxis. 3. Vitamin E also has the antioxidant effect of carotene, and the soft capsule according to the present invention is also safe and safe in this respect.
High stability.
【0026】[0026]
【実施例】以下実施例をもって本発明を詳細に説明する
が、本発明はこれらの実施例に限定されない。請求項1
に対応する実施例について説明する。 比較例1 表1のカプセル皮膜液及びカプセル内容液を調合し、以
下スタンピング法の一種であるロータリーダイ法により
製し、直径約8mmの球状のゼラチン製ソフトカプセル
を得た。The present invention will be described in detail with reference to the following examples, but the present invention is not limited to these examples. Claim 1
An example corresponding to will be described. Comparative Example 1 The capsule coating solution and the capsule content solution shown in Table 1 were mixed and manufactured by a rotary die method, which is one of the stamping methods, to obtain spherical gelatin soft capsules having a diameter of about 8 mm.
【0027】[0027]
【表1】 [Table 1]
【0028】比較例2 内容液として1%アセトアルデヒド含有中鎖脂肪酸トリ
グリセリドを用い、比較例1と同様に直径約8mmの球
状のゼラチン製ソフトカプセルを得た。 比較例3 表2のカプセル皮膜液及びカプセル内容液を調合し、以
下ドリッピング法により直径約8mmの球状のソフトカ
プセルを得た。Comparative Example 2 Using the medium-chain fatty acid triglyceride containing 1% acetaldehyde as the content liquid, spherical soft gelatin capsules having a diameter of about 8 mm were obtained in the same manner as in Comparative Example 1. Comparative Example 3 The capsule coating solution and the capsule content solution shown in Table 2 were prepared, and spherical soft capsules having a diameter of about 8 mm were obtained by the dripping method.
【0029】[0029]
【表2】 [Table 2]
【0030】実施例1 表3のカプセル皮膜液及びカプセル内容液を調合し、以
下ドリッピング法により直径約8mmの球状のソフトカ
プセルを得た。Example 1 The capsule coating solution and the capsule content solution shown in Table 3 were prepared, and spherical soft capsules having a diameter of about 8 mm were obtained by the dripping method.
【0031】[0031]
【表3】 [Table 3]
【0032】実施例2 表4のカプセル皮膜液及びカプセル内容液を調合し、実
施例1と同様にしてソフトカプセルを得た。Example 2 A capsule capsule solution and a capsule content solution shown in Table 4 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0033】[0033]
【表4】 [Table 4]
【0034】実施例3 表5のカプセル皮膜液及びカプセル内容液を調合し、実
施例1と同様にしてソフトカプセルを得た。Example 3 A capsule capsule solution and a capsule content solution shown in Table 5 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0035】[0035]
【表5】 [Table 5]
【0036】実施例4 表6のカプセル皮膜液及びカプセル内容液を調合し、実
施例1と同様にしてソフトカプセルを得た。Example 4 A capsule capsule solution and a capsule content solution shown in Table 6 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0037】[0037]
【表6】 [Table 6]
【0038】実施例5 表7のカプセル皮膜液及びカプセル内容液を調合し、実
施例1と同様にしてソフトカプセルを得た。Example 5 The capsule coating solution and the capsule content solution shown in Table 7 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0039】[0039]
【表7】 [Table 7]
【0040】実施例6Example 6
【0041】表8のカプセル皮膜液及びカプセル内容液
を調合し、実施例1と同様にしてソフトカプセルを得
た。The capsule coating solution and the capsule content solution shown in Table 8 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0042】[0042]
【表8】 [Table 8]
【0043】実施例7Example 7
【0044】表9のカプセル皮膜液及びカプセル内容液
を調合し、実施例1と同様にしてソフトカプセルを得
た。The capsule coating liquid and the capsule content liquid shown in Table 9 were prepared and soft capsules were obtained in the same manner as in Example 1.
【0045】[0045]
【表9】 [Table 9]
【0046】尚、比較例1〜比較例3、実施例1〜実施
例7のカプセルは、カプセル成形時、スタンピング法に
おいてはライナー式ロータリーダイ自動カプセル成形機
の改良機を用いて成形し、カプセル成形後、乾燥、脱
油、選別工程を得て製したものである。上記の各カプセ
ルについて各種評価試験を行ったので以下に示した。The capsules of Comparative Examples 1 to 3 and Examples 1 to 7 were molded by using a modified liner type rotary die automatic capsule molding machine in the stamping method during capsule molding. After molding, it is manufactured by the steps of drying, deoiling and sorting. Various evaluation tests were performed on the above capsules, and the results are shown below.
【0047】1.カプセル内容液放出試験 日本薬局方崩壊試験のうち、腸溶性の製剤用試験に従っ
て比較例1〜比較例3、実施例1〜実施例7の各カプセ
ルを検体として試験した。結果は表10のとおりであっ
た。1. Capsule content liquid release test Among the Japanese Pharmacopoeia disintegration tests, the capsules of Comparative Examples 1 to 3 and Examples 1 to 7 were tested as samples according to the enteric coating test. The results are shown in Table 10.
【0048】[0048]
【表10】 [Table 10]
【0049】表10の結果から明らかなように本実施例
のカプセルはいずれも腸溶性崩壊試験適合であったのに
対し、比較例はいずれも不適合であり、本実施例では以
下の結果が認めれられた。As is clear from the results in Table 10, all the capsules of this example were compatible with the enteric disintegration test, whereas all the comparative examples were not compatible, and the following results were observed in this example. Was given.
【0050】1)ゼラチンカプセルはカプセル内容液の
成分(例:アルデヒド類)と反応してカプセル皮膜が不
溶化するが(比較例2)、本実施例の皮膜は安定であっ
た。 2)寒天単独をゲル化・造膜成分とするカプセルはカプ
セル内溶液の放出が認められず、医薬品及び食品用カプ
セルとして最も致命的な欠点を有することが認められ
た。1) Gelatin capsules react with the components (eg, aldehydes) of the capsule content liquid to insolubilize the capsule film (Comparative Example 2), but the film of this Example was stable. 2) It was confirmed that the capsule containing agar alone as a gelling / film-forming component did not release the solution in the capsule, and had the most fatal drawback as a capsule for pharmaceuticals and foods.
【0051】2.カプセル安定性試験 耐高温・耐高湿度に関する安定性を評価するため、試験
したので以下に示す。比較例1〜比較例3、実施例1〜
実施例7までのカプセル50球をとり、ガラス瓶に入
れ、栓をしない状態で40°C、RH75%下に24時
間保存し、保存後、カプセルの熱・湿気による外観変化
及びカプセル同志あるいは瓶との付着性を評価した。結
果を表11、表12に示した。2. Capsule stability test A test was conducted to evaluate the stability with respect to high temperature and high humidity resistance. Comparative Example 1-Comparative Example 3, Example 1-
Take 50 capsules of the capsules up to Example 7, put them in a glass bottle, store them at 40 ° C., 75% RH for 24 hours without stopper, and after storage, change the appearance of the capsules due to heat and humidity and the same capsule or bottle. Was evaluated. The results are shown in Tables 11 and 12.
【0052】[0052]
【表11】 [Table 11]
【0053】[0053]
【表12】 [Table 12]
【0054】3.カプセルの強度 カプセルの強度を評価するため、錠剤の硬度計で5kg
の荷重を30秒間加え、カプセルが破裂するか否かを試
験したので結果を表13に示す。3. Strength of capsules To evaluate the strength of capsules, use a tablet hardness tester to measure 5 kg.
The load was applied for 30 seconds to test whether or not the capsule burst, and the results are shown in Table 13.
【0055】[0055]
【表13】 [Table 13]
【0056】表11〜表13に示すように、本実施例の
カプセルは、いずれも従来のカプセルに比し、耐高温
性、耐高湿度性、付着性、カプセル強度等、安定性、取
り扱いやすさ等の点ですぐれていることが認められた。As shown in Tables 11 to 13, each of the capsules of this example has higher temperature resistance, high humidity resistance, adhesiveness, capsule strength, stability, ease of handling, etc. than conventional capsules. It was recognized that it was excellent in terms of quality.
【0057】4.タンパク質の確認 比較例及び実施例の各ソフトカプセルについて、タンパ
ク質の定性反応(確認試験)として最も一般的な「ビュ
レット反応」を行い、タンパク質が含まれているか否か
を確認した。結果を表14に示す。本実施例は陰性で、
タンパク質は検出されなかった。4. Confirmation of protein For each soft capsule of the comparative example and the example, the most common "burette reaction" as a qualitative reaction (confirmation test) of protein was performed to confirm whether or not the protein was contained. The results are shown in Table 14. This example is negative,
No protein was detected.
【0058】[0058]
【表14】 [Table 14]
【0059】以上のように本発明による動物性タンパク
質を含まない易溶解性のソフトカプセルは医薬品及び食
品用のソフトカプセルとして、菜食主義者や宗教的理由
あるいは動物タンパクにアレルギーを示す人なども安全
に食することができ、かつ体内での医薬品・食品成分の
吸収が容易で、耐熱性、耐湿度性も高く、従来のカプセ
ルより優れていた。As described above, the easily-dissolved soft capsule containing no animal protein according to the present invention is used as a soft capsule for medicines and foods, and can be safely eaten by vegetarians, people who have religious reasons or who are allergic to animal proteins. In addition, it is easy to absorb pharmaceuticals and food ingredients in the body, and has high heat resistance and high humidity resistance, which is superior to conventional capsules.
【0060】請求項2に対応する実施例について説明す
る。 予備試験 カロチンの油性液の沈降分離に対するビタミンEの効果
を確認するため、表15、表16に示す処方の油性液を
調製し、直径約1.5cmのガラス製試験管に高さ10
cmまで入れ、室温で静置し、カロチンの沈降の有無を
1日後、7日後に観察した。An embodiment corresponding to claim 2 will be described. Preliminary test In order to confirm the effect of vitamin E on the sedimentation and separation of oily liquid of carotene, oily liquids having the formulations shown in Tables 15 and 16 were prepared and placed in a glass test tube having a diameter of about 1.5 cm at a height of 10 cm.
cm, and allowed to stand still at room temperature, and the presence or absence of carotene precipitation was observed after 1 day and 7 days.
【0061】[0061]
【表15】 [Table 15]
【0062】[0062]
【表16】 [Table 16]
【0063】各原料はいずれもそのままの組成のものを
市販品として入手した。又、この検体1〜6につき、遠
心分離機で3000rpmで15分間の負荷を加え、沈
降を加速させ分離の有無を確認した。結果は表17に示
すとおりであった。Each raw material was obtained as a commercial product with the same composition. In addition, a load of 3000 rpm for 15 minutes was applied to each of the samples 1 to 6 by a centrifuge to accelerate sedimentation and confirm the presence or absence of separation. The results are shown in Table 17.
【0064】[0064]
【表17】 [Table 17]
【0065】添加物を用いず一般の食用油のみを基剤と
した検体1、2ではカロチンの明らかな沈降分離が認め
られたのに対し、増粘剤・界面活性剤等の添加物を用い
て、カロチンの沈降防止を行った検体3、4及び基剤と
してビタミンEを用いた検体5、6は沈殿は認められず
安定であった。In Samples 1 and 2 in which only general edible oil was used as a base without additives, clear precipitation and separation of carotene was observed, whereas additives such as thickeners and surfactants were used. As a result, Samples 3 and 4 in which carotene was prevented from settling and Samples 5 and 6 in which vitamin E was used as a base were stable without precipitation.
【0066】実施例1 表18の処方のカロチンの油性液を調合して、ソフトカ
プセル内溶液とし、常法に従い、ロータリーダイ式ソフ
トカプセル製造機により、ソフトカプセルを製した。Example 1 An oil solution of carotene having the formulation shown in Table 18 was blended to prepare a solution in a soft capsule, and a soft capsule was produced by a rotary die type soft capsule producing machine according to a conventional method.
【0067】[0067]
【表18】 [Table 18]
【0068】このソフトカプセルはoval型で、カプ
セル皮膜重量は、95mgで、皮膜の組成はゼラチン1
00重量部、グリセリン25重量部であった。このカプ
セルにつき、6号規格ガラス管に入れ、密栓して、40
°Cに2ヶ月間保存し、安定性を確認したところ、表1
9に示すとおり、本発明例(カプセル3)のカプセルは
安定であり、外観の異状は認められず、従来の添加物使
用カプセルと(カプセル2)同様に安定であった。これ
に対し、添加物を含まないカプセル1は内容液が2層に
分離した。This soft capsule is an oval type, the capsule coating weight is 95 mg, and the coating composition is gelatin 1
It was 00 parts by weight and 25 parts by weight of glycerin. Put this capsule in a No. 6 standard glass tube, seal it tightly, and
It was stored in ° C for 2 months and its stability was confirmed.
As shown in FIG. 9, the capsule of the present invention example (capsule 3) was stable, no abnormal appearance was observed, and was stable as the conventional additive-containing capsule (capsule 2). On the other hand, the content liquid of the capsule 1 containing no additive separated into two layers.
【0069】[0069]
【表19】 [Table 19]
Claims (2)
側の吐出口からカプセル内容液を又外側の吐出口からカ
プセル皮膜液をポンプ又は重力により一定速度で、油液
中又は気体中に吐出し、振動、衝撃、カプセル液と油液
又は気体との流速差等何らかの物理的力により、この吐
出液を一定間隔で切断し、油液又は気体とカプセル皮膜
液との界面又は表面張力により、この切断部を直径0.
3mm〜20mmの球状のソフトカプセルとする方法に
より製したソフトカプセルにおいて、そのソフトカプセ
ル皮膜が、下記の三つの成分からなり、動物性タンパク
質を含まない易溶解性で可食性のカプセル皮膜である事
を特徴とする安全性の高い食品及び医薬品用ソフトカプ
セル。 1)易溶解性の造膜性基剤 水に溶解性で、その1%水溶液の粘度が70°Cで10
00cps以下であり、動物性タンパク質を含まない可
食性の高分子物質(アルギン酸及びその塩類、カラギー
ナン、デキストリンなど) 2)ゲル化及び造膜性基剤 寒天及び(又は)ゼリー強度300g/cm2以下の低
分子寒天 3)可塑剤 グリセリン、ソルビトールなどClaims: 1. A capsule content liquid is discharged from an inner discharge port of a double or triple structure discharge port (nozzle) and a capsule coating liquid is discharged from an outer discharge port in an oil liquid or a gas at a constant speed by a pump or gravity. The discharge liquid is cut at a constant interval by some physical force such as vibration, shock, flow velocity difference between the capsule liquid and the oil liquid or gas, and the interface or surface tension between the oil liquid or gas and the capsule coating liquid is cut. This cut portion has a diameter of 0.
A soft capsule produced by a method of forming a spherical soft capsule of 3 mm to 20 mm, characterized in that the soft capsule film is composed of the following three components and is an easily soluble and edible capsule film containing no animal protein. Safe capsules for foods and pharmaceuticals with high safety. 1) An easily soluble film-forming base that is soluble in water and has a viscosity of a 1% aqueous solution of 10 at 70 ° C.
Edible high-molecular substances (alginic acid and its salts, carrageenan, dextrin, etc.) that are less than 00 cps and do not contain animal protein 2) Gelling and film-forming base Agar and / or jelly strength 300 g / cm 2 or less Low molecular weight agar 3) Plasticizers such as glycerin and sorbitol
チン類の5倍量以上のビタミンEを含むソフトカプセル
であり、カプセル内容液はカロチン類、ビタミンE、そ
の他の有効成分及び食用植物油からなり、増粘剤、分散
剤等のいわゆる食品添加物を含まない事を特徴とする安
全性の高い食品及び医薬品用ソフトカプセル。2. A soft capsule containing 1 mg or more of carotenes and 5 times more amount of vitamin E than carotenes in one bulb, and the capsule content liquid comprises carotene, vitamin E, other active ingredients and edible vegetable oil. A highly safe food and pharmaceutical soft capsule characterized by not containing so-called food additives such as a thickener and a dispersant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5351267A JPH07196478A (en) | 1993-12-30 | 1993-12-30 | Soft capsule for highly safe food and medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5351267A JPH07196478A (en) | 1993-12-30 | 1993-12-30 | Soft capsule for highly safe food and medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07196478A true JPH07196478A (en) | 1995-08-01 |
Family
ID=18416164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5351267A Pending JPH07196478A (en) | 1993-12-30 | 1993-12-30 | Soft capsule for highly safe food and medicine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07196478A (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6333047B1 (en) | 1997-05-09 | 2001-12-25 | Daiichi Kasei Co., Ltd. | Molded capsule superior in strength and stability and method for preparing same |
| EP1105108A4 (en) * | 1998-08-25 | 2004-04-07 | Banner Pharmacaps Inc | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| WO2004096283A1 (en) * | 2003-05-02 | 2004-11-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Soft capsule film and soft capsule |
| EP1508591A1 (en) * | 2003-08-22 | 2005-02-23 | Symrise GmbH & Co. KG | Wrapping material for seamless capsules |
| US6949256B2 (en) | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
| WO2007003113A1 (en) * | 2005-07-01 | 2007-01-11 | Liande Tang | A composition of raw materials for a plant polyose-containing hollow capsule and the properation method of such capsure |
| GB2430364A (en) * | 2005-09-22 | 2007-03-28 | Carl Ernest Alexander | Soft agar bolus for oral drug delivery |
| WO2008120711A1 (en) | 2007-03-30 | 2008-10-09 | Tmrc Co., Ltd. | Tamibarotene capsule preparation |
| EP2100594A1 (en) | 2008-03-14 | 2009-09-16 | Symrise GmbH & Co. KG | Ternary mixtures with increased collagen synthesis |
| EP2168570A2 (en) | 2008-09-30 | 2010-03-31 | Symrise GmbH & Co. KG | Extracts of isochrysis sp. |
| EP2193785A2 (en) | 2008-12-05 | 2010-06-09 | Symrise GmbH & Co. KG | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes |
| US7766637B2 (en) | 2006-03-03 | 2010-08-03 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| JP2010252663A (en) * | 2009-04-23 | 2010-11-11 | Ajinomoto Co Inc | Method for producing spherical jelly |
| US7887838B2 (en) | 2002-01-18 | 2011-02-15 | Banner Pharmacaps, Inc. | Non-gelatin film and method and apparatus for producing same |
| US7972620B2 (en) | 2002-04-04 | 2011-07-05 | Fmc Biopolymer As | Polysaccharide capsules and methods of preparation |
| WO2016017006A1 (en) * | 2014-07-31 | 2016-02-04 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | Capsule formulation |
| JP2016033119A (en) * | 2014-07-31 | 2016-03-10 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV | Capsule formulation |
| US9339060B2 (en) | 2005-06-21 | 2016-05-17 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| US9676150B2 (en) | 2011-08-10 | 2017-06-13 | British American Tobacco (Investments) Limited | Capsule formation |
| US10231934B2 (en) | 2009-09-24 | 2019-03-19 | Capsugel Belgium Nv | Acid resistant capsules |
| US10238141B2 (en) | 2011-08-10 | 2019-03-26 | British American Tobacco (Investments) Limited | Capsule formation |
| CN109512795A (en) * | 2018-12-24 | 2019-03-26 | 浙江安宝药业有限公司 | Vitamin A soft capsule |
| WO2019167934A1 (en) * | 2018-02-28 | 2019-09-06 | 三生医薬株式会社 | Coating composition and capsule using coating composition |
| KR20200104706A (en) * | 2019-02-27 | 2020-09-04 | 주식회사 한국인삼공사 | Multilayer Coating Soft Capsule |
| WO2022129101A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Extracts of isochrysis species / tisochrysis species |
| WO2022128164A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Extracts of isochrysis species / tisochrysis species |
| US20220249368A1 (en) * | 2019-08-30 | 2022-08-11 | Procaps S.A. | Heat resistant chewable oral form with an agar matrix and manufacturing process thereof |
-
1993
- 1993-12-30 JP JP5351267A patent/JPH07196478A/en active Pending
Cited By (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6333047B1 (en) | 1997-05-09 | 2001-12-25 | Daiichi Kasei Co., Ltd. | Molded capsule superior in strength and stability and method for preparing same |
| EP1105108A4 (en) * | 1998-08-25 | 2004-04-07 | Banner Pharmacaps Inc | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| US6949256B2 (en) | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
| US7887838B2 (en) | 2002-01-18 | 2011-02-15 | Banner Pharmacaps, Inc. | Non-gelatin film and method and apparatus for producing same |
| US9017720B2 (en) | 2002-04-04 | 2015-04-28 | FMC Bioploymer AS | Polysaccharide capsules and method of preparation |
| US7972620B2 (en) | 2002-04-04 | 2011-07-05 | Fmc Biopolymer As | Polysaccharide capsules and methods of preparation |
| WO2004096283A1 (en) * | 2003-05-02 | 2004-11-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Soft capsule film and soft capsule |
| JPWO2004096283A1 (en) * | 2003-05-02 | 2006-07-13 | 株式会社林原生物化学研究所 | Soft capsule film and soft capsule |
| JP2011153147A (en) * | 2003-05-02 | 2011-08-11 | Hayashibara Biochem Lab Inc | Soft capsule film and soft capsule |
| EP1508591A1 (en) * | 2003-08-22 | 2005-02-23 | Symrise GmbH & Co. KG | Wrapping material for seamless capsules |
| WO2005021635A1 (en) * | 2003-08-22 | 2005-03-10 | Symrise Gmbh & Co. Kg | Covering material for seamless capsules |
| US9339060B2 (en) | 2005-06-21 | 2016-05-17 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| US10278418B2 (en) | 2005-06-21 | 2019-05-07 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
| WO2007003113A1 (en) * | 2005-07-01 | 2007-01-11 | Liande Tang | A composition of raw materials for a plant polyose-containing hollow capsule and the properation method of such capsure |
| GB2430364A (en) * | 2005-09-22 | 2007-03-28 | Carl Ernest Alexander | Soft agar bolus for oral drug delivery |
| US8153037B2 (en) | 2006-03-03 | 2012-04-10 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| US7766637B2 (en) | 2006-03-03 | 2010-08-03 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| US8916192B2 (en) | 2006-03-03 | 2014-12-23 | Fmc Corporation | Method and apparatus for the preparation of capsules |
| WO2008120711A1 (en) | 2007-03-30 | 2008-10-09 | Tmrc Co., Ltd. | Tamibarotene capsule preparation |
| EP2100594A1 (en) | 2008-03-14 | 2009-09-16 | Symrise GmbH & Co. KG | Ternary mixtures with increased collagen synthesis |
| EP2100593A1 (en) | 2008-03-14 | 2009-09-16 | Symrise GmbH & Co. KG | Ternary mixtures with increased collagen synthesis |
| EP2168570A2 (en) | 2008-09-30 | 2010-03-31 | Symrise GmbH & Co. KG | Extracts of isochrysis sp. |
| EP3348255A1 (en) | 2008-12-05 | 2018-07-18 | Symrise AG | Extracts of tetraselmis sp. for cosmetic and therapeutic purposes |
| EP2193785A2 (en) | 2008-12-05 | 2010-06-09 | Symrise GmbH & Co. KG | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes |
| US9445988B2 (en) | 2008-12-05 | 2016-09-20 | Symrise Ag | Extracts of Tetraselmis sp |
| JP2010252663A (en) * | 2009-04-23 | 2010-11-11 | Ajinomoto Co Inc | Method for producing spherical jelly |
| US10874619B2 (en) | 2009-09-24 | 2020-12-29 | Capsugel Belgium, NV | Acid resistant capsules |
| US10231934B2 (en) | 2009-09-24 | 2019-03-19 | Capsugel Belgium Nv | Acid resistant capsules |
| US10238141B2 (en) | 2011-08-10 | 2019-03-26 | British American Tobacco (Investments) Limited | Capsule formation |
| US9676150B2 (en) | 2011-08-10 | 2017-06-13 | British American Tobacco (Investments) Limited | Capsule formation |
| WO2016017006A1 (en) * | 2014-07-31 | 2016-02-04 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | Capsule formulation |
| JP2016033119A (en) * | 2014-07-31 | 2016-03-10 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV | Capsule formulation |
| WO2019167934A1 (en) * | 2018-02-28 | 2019-09-06 | 三生医薬株式会社 | Coating composition and capsule using coating composition |
| US12194152B2 (en) | 2018-02-28 | 2025-01-14 | Sunsho Pharmaceutical Co., Ltd. | Shell composition and capsule using the shell composition |
| JPWO2019167934A1 (en) * | 2018-02-28 | 2021-02-12 | 三生医薬株式会社 | Film composition and capsules using the film composition |
| CN109512795A (en) * | 2018-12-24 | 2019-03-26 | 浙江安宝药业有限公司 | Vitamin A soft capsule |
| WO2020175894A3 (en) * | 2019-02-27 | 2020-12-10 | 주식회사 한국인삼공사 | Multi-coated soft capsule |
| KR20200104706A (en) * | 2019-02-27 | 2020-09-04 | 주식회사 한국인삼공사 | Multilayer Coating Soft Capsule |
| US20220249368A1 (en) * | 2019-08-30 | 2022-08-11 | Procaps S.A. | Heat resistant chewable oral form with an agar matrix and manufacturing process thereof |
| WO2022129101A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Extracts of isochrysis species / tisochrysis species |
| WO2022128164A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Extracts of isochrysis species / tisochrysis species |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH07196478A (en) | Soft capsule for highly safe food and medicine | |
| TWI405592B (en) | Non-gelatin soft capsule system | |
| KR101292573B1 (en) | Jelly composition | |
| EP0683666B1 (en) | Water based beverages | |
| US20050249676A1 (en) | Pullulan capsules | |
| ES3033915T3 (en) | Pullulan capsules | |
| EP3082778B1 (en) | Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid | |
| KR20180040139A (en) | Enteric capsule | |
| WO2004096283A1 (en) | Soft capsule film and soft capsule | |
| EP1385552B1 (en) | Oral delivery method and composition for solid medications or dietary supplements | |
| US20200230067A1 (en) | Suspensions of encapsulated pharmaceuticals and methods of making and using the same | |
| WO2002026264A1 (en) | Oral delivery method and composition for solid medications or dietary supplements in the form of solid particles | |
| US11224574B1 (en) | Gel-inducible composition for pet administration assistance | |
| KR102894940B1 (en) | Stable lactase products | |
| CN111358000B (en) | Oily composition containing carotene | |
| US11833182B2 (en) | Sleep product | |
| RU2852588C1 (en) | Method for producing tetravit microcapsules in gelatin shell | |
| CN101296687A (en) | Soft agar bolus for oral drug delivery | |
| CA2991719C (en) | Pharmaceutical compositions | |
| WO2024080884A1 (en) | Pharmaceutical compositions of tretinoin and methods of producing such compositions | |
| Reddy et al. | Available online at www. JGTPS. com | |
| Bhatt et al. | capsules | |
| Agrawal et al. | Dr. Bhawna Bhatt Delhi Institute of Pharmaceutical Science and Research Sector–3, Pushp Vihar New Delhi | |
| HK1155073B (en) | Non-gelatin soft capsule system |